Journal article

Novel agents versus chemotherapy as frontline treatment of CLL

Anna Piggin, Emma Bayly, Constantine S Tam

Leukemia & Lymphoma | TAYLOR & FRANCIS LTD | Published : 2017

DOI: 10.1080/10428194.2017.1280606

Citation metrics

3Web of Science
3Scopus

Keywords

Molecular Targeted Therapy
Fludarabine
Comorbidity
Life Sciences & Biomedicine
Science & Technology
Humans
Immunotherapy
Protein Kinase Inhibitors
Chromosomes, Human, Pair 11
Previously Untreated Patients
Chemoimmunotherapy
Cyclophosphamide
Hematology
Clinical Trials As Topic
Aged
Initial Therapy
Idelalisib
Male
Chromosome Deletion
Venetoclax
Pyrimidines
Rituximab
Chronic Lymphocytic-Leukemia
Mutation
Female
Middle Aged
Antineoplastic Combined Chemotherapy Protocols
Treatment Outcome
Open-Label
Pyrazoles
Obinutuzmab
Oncology
Phase-3 Trial
Leukemia, Lymphocytic, Chronic, B-Cell
Immunoglobulin Heavy Chains
Ibrutinib
Chromosomes, Human, Pair 13